Sphamandla Mtambo

7PUBLICATIONS
9CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
An interpretable consensus pipeline for candidate dopamine D2 receptor ligands.

|Mar 29, 2023
Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation.

Aganze G Mushebenge, Samuel C Ugbaja, Sphamandla E Mtambo

|Jul 27, 2022
In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus.

Sphamandla E Mtambo, Hezekiel M Kumalo

|Jul 27, 2022
Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus.

Samuel C Ugbaja, Sphamandla E Mtambo, Aganze G Mushebenge

|Mar 10, 2022
Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective.

Sphamandla E Mtambo, Samuel C Ugbaja, Hezekiel M Kumalo

|Mar 10, 2022
Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus' Susceptibility to E119V-Substituted Peramivir-Neuraminidase Complex.

Sphamandla E Mtambo, Samuel C Ugbaja, Aganze G Mushebenge

Pageof 2

Frequent Collaborators

3 joint publications

Mthobisi L Ntuli

2 joint publications

Rene Khan

1 joint publications

Daniel G Amoako

1 joint publications

Anou M Somboro